EVIDENCE-BASED SUPPLEMENT SCORING
5.5/10
AVERAGE

Confidence: 75%

Toniiq GLP-1 Support — with Clinically Studied, Patented GlucoVantage® Dihydroberberine and Akkermansia — Appetite and Fullness Support — 120 Capsules (60-Day Supply)

Toniiq GLP-1 Support — with Clinically Studied, Patented GlucoVantage® Dihydroberberine and Akkermansia — Appetite and Fullness Support — 120 Capsules (60-Day Supply)

B0F7RVJBFK

View on Amazon →

Decision summary

CONSIDERAVERAGE

Not a strong option overall. The product is materially held back by weaker formulation coherence.

Best for

Buyers comparing price and availability and okay with a middle-of-the-pack option.

Consider another option if

You want one of the best-absorbed options in this category.

Score breakdown

Tap a module to see what it measures. A 0 can reflect missing disclosure, not just a negative result.

Dosage quality

4.7/10

Dosing looks weaker than ideal

Checks whether labeled ingredient amounts fall within clinically studied ranges (not just regulatory minimums). Low/0 can reflect under-dosing or missing amounts (e.g., proprietary blends).

Multi-ingredient formulation analysis

Dose 4.7/10 · Bioavailability 3.1/10 · Coherence 0/10

Dose quality suggests a diluted formulation.

Ingredient form quality suggests suboptimal ingredient forms.

This is a multi-ingredient product. The score reflects formulation quality, not efficacy for a specific health goal.

Score summary

Quercetin: high-bioavailability form declared (Quercetin Dihydrate). The main limitation is that critical safety flag limits final score.

Strengths

Quercetin: high-bioavailability form declared (Quercetin Dihydrate)
Chromium: high-bioavailability form declared (Chromium Picolinate)

Weaknesses

Critical safety flag limits final score
Formula coherence is weak: diluted, decorative or overly complex
Inulin: below clinically studied range

Final verdict

Not a strong option overall. The product is materially held back by weaker formulation coherence.

Ingredient Analysis & Evidence

A closer look at the main ingredients, how they influence the score, and the supporting evidence when available. Tap any ingredient to expand.

Evidence inferred from established knowledge, not directly linked studies

Supports the formula, but not a major driver: Clinical dosing guidance is limited for this ingredient.

No supporting studies or dosing references are currently available for this ingredient.

ℹ Dose is below the optimal range with moderate supporting evidence

Adequate, but not a key strength: Dose is directionally useful, but not a standout strength. The declared form supports strong absorption.

Scientific evidence

Meta-analysis

Guo et al. meta-analysis quercetin and antioxidant markers

Phytotherapy Research • 2017

PMID: 27995808.0

RCT

Nieman et al. RCT quercetin and upper respiratory tract infections

Nutrients • 2007

PMID: 19965765.0

✔ Clinically effective dose with moderate supporting evidence

This is a limiting factor: Dose is higher than typically recommended ranges. The declared form supports strong absorption.

Scientific evidence

Meta-analysis

Balk et al. systematic review chromium picolinate and glycemic control

Diabetes Technology & Therapeutics • 2007

PMID: 17519436.0

⚠ Dose is below commonly used clinical ranges

This is a limiting factor: Dose is likely below clinically useful levels.

Clinical dosing guidance

Based on established dosing ranges used in clinical practice.

Min effective: 1000 mgOptimal: 2000 mgUpper: 4000 mgGrade: B

⚠ Moderate evidence exists, but dose is below effective threshold

This is a limiting factor: Dose is likely below clinically useful levels.

Scientific evidence

Meta-analysis

Niness and Holbrook review inulin bifidogenic effect

Journal of Nutrition • 2007

PMID: 24898241.0

Evidence inferred from established knowledge, not directly linked studies

Supports the formula, but not a major driver: Clinical dosing guidance is limited for this ingredient.

No supporting studies or dosing references are currently available for this ingredient.

Toniiq GLP-1 Support — with Clinically Studied, Patented GlucoVantage® Dihydroberberine and Akkermansia — Appetite and Fullness Support — 120 Capsules (60-Day Supply)

Toniiq GLP-1 Support — with Clinically Studied, Patented GlucoVantage® Dihydroberberine and Akkermansia — Appetite and Fullness Support — 120 Capsules (60-Day Supply)

Warnings & notes

Important label or formulation details that may affect how this product should be interpreted.

!

Safety-related concerns may affect suitability

This product may deserve extra caution depending on context.

Warning

Formula design looks less coherent than stronger alternatives

The formulation appears less focused than better-built options.

Note
!

Inulin dose looks below clinically effective levels

Declared amount falls below ranges used in human trials.

Warning

Methodology

Read our methodology overview to understand how SuppScoreLab combines multiple scientific dimensions into one practical score.

View methodology →

This evaluation is based on the product label and declared Supplement Facts available at review time. It does not verify laboratory-tested composition, purity, or batch-level quality. This content is educational and not medical advice. Consult a qualified healthcare professional for personal health decisions. Affiliate disclosure: SuppScoreLab may earn a commission from qualifying Amazon links.

Still comparing options?

See the best Berberine supplements ranked with the same methodology, or keep exploring the database.

As an Amazon Associate I earn from qualifying purchases.